Skip to main content
Erschienen in: Rheumatology International 3/2009

01.01.2009 | Original Paper

Circulating E-selectin and tumor necrosis factor-α in extraarticular involvement and joint disease activity in rheumatoid arthritis

verfasst von: Esther G. Corona-Sanchez, Laura Gonzalez-Lopez, Jose F. Muñoz-Valle, Monica Vazquez-Del Mercado, Maria A. Lopez-Olivo, Erika A. Aguilar-Chavez, Mario Salazar-Paramo, Carlos Loaiza-Cardenas, Edith Oregon-Romero, Rosa E. Navarro-Hernandez, Jorge I. Gamez-Nava

Erschienen in: Rheumatology International | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

In this cross-sectional study, we assessed the relationship between circulating TNF-α and E-selectin (sE-selectin) with extraarticular involvement and severity of joint disease in RA. We compared 56 patients who had RA and extraarticular involvement (ExRA) with a group of 84 patients with only articular involvement (non-ExRA). ExRA had higher circulating TNF-α than non-ExRA (32 ± 9 vs. 28 ± 6 pg/mL, P = 0.002). sE-selectin levels did not differ between both groups. sE-selectin correlated with tender joint count (rho = 0.19, P = 0.03), morning stiffness (rho = 0.19, P = 0.03), severity of pain (rho = 0.21, P = 0.02), disease activity (assessed by the patient) (rho = 0.21, P = 0.02), HAQ-DI (rho = 0.29, P = 0.004), and rheumatoid factor titers (rho = 0.31, P = <0.001). Circulating TNF-α had no correlation with sE-selectin or disease activity. We concluded that sE-selectin correlated with severity of joint disease, further follow-up studies should evaluate if sE-selectin is useful as prognosis marker for progression of articular damage.
Literatur
2.
Zurück zum Zitat Calgüneri M, Ureten K, Akif Oztürk M, Onat AM, Ertenli I, Kiraz S et al (2006) Extra-articular manifestations of rheumatoid arthritis: results of a university hospital of 526 patients in Turkey. Clin Exp Rheumatol 24:305–308PubMed Calgüneri M, Ureten K, Akif Oztürk M, Onat AM, Ertenli I, Kiraz S et al (2006) Extra-articular manifestations of rheumatoid arthritis: results of a university hospital of 526 patients in Turkey. Clin Exp Rheumatol 24:305–308PubMed
3.
Zurück zum Zitat Turesson C, O’Fallon WM, Crowson CS, Gabriel SE, Matteson EL (2002) Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 29:62–67PubMed Turesson C, O’Fallon WM, Crowson CS, Gabriel SE, Matteson EL (2002) Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 29:62–67PubMed
6.
Zurück zum Zitat Kuryliszyn-Moskal A (1998) Cytokines and soluble CD4 and CD8 molecules in rheumatoid arthritis: relationship to systematic vasculitis and microvascular capillaroscopic abnormalities. Clin Rheumatol 17:489–495. doi:10.1007/BF01451285 PubMedCrossRef Kuryliszyn-Moskal A (1998) Cytokines and soluble CD4 and CD8 molecules in rheumatoid arthritis: relationship to systematic vasculitis and microvascular capillaroscopic abnormalities. Clin Rheumatol 17:489–495. doi:10.​1007/​BF01451285 PubMedCrossRef
7.
Zurück zum Zitat Turesson C, Englund P, Jacobsson LT, Sturfelt G, Truedsson L, Nennesmo I et al (2001) Increased endothelial expression of HLA-DQ and interleukin 1alpha in extra-articular rheumatoid arthritis. Results from immunohistochemical studies of skeletal muscle. Rheumatology (Oxford) 40:1346–1354. doi:10.1093/rheumatology/40.12.1346 CrossRef Turesson C, Englund P, Jacobsson LT, Sturfelt G, Truedsson L, Nennesmo I et al (2001) Increased endothelial expression of HLA-DQ and interleukin 1alpha in extra-articular rheumatoid arthritis. Results from immunohistochemical studies of skeletal muscle. Rheumatology (Oxford) 40:1346–1354. doi:10.​1093/​rheumatology/​40.​12.​1346 CrossRef
9.
Zurück zum Zitat Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik JP, Cylwik B, Skowronski J et al (2002) Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis. Ann Rheum Dis 61:804–809. doi:10.1136/ard.61.9.804 PubMedCrossRef Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik JP, Cylwik B, Skowronski J et al (2002) Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis. Ann Rheum Dis 61:804–809. doi:10.​1136/​ard.​61.​9.​804 PubMedCrossRef
10.
Zurück zum Zitat Navarro-Hernández RE, Oregón-Romero E, Rangel-Villalobos H, Vázquez-Del Mercado M, Ruiz-Quezada SL, Maldonado-González M et al (2006) sE-Selectin expression and A561C polymorphism in relation to rheumatoid arthritis clinical activity. J Rheumatol 33:1968–1972PubMed Navarro-Hernández RE, Oregón-Romero E, Rangel-Villalobos H, Vázquez-Del Mercado M, Ruiz-Quezada SL, Maldonado-González M et al (2006) sE-Selectin expression and A561C polymorphism in relation to rheumatoid arthritis clinical activity. J Rheumatol 33:1968–1972PubMed
11.
12.
Zurück zum Zitat Salih AM, Nixon NB, Dawes PT, Mattey DL (1999) Soluble adhesion molecules and anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by peripheral neuropathy. J Rheumatol 26:551–555PubMed Salih AM, Nixon NB, Dawes PT, Mattey DL (1999) Soluble adhesion molecules and anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by peripheral neuropathy. J Rheumatol 26:551–555PubMed
13.
Zurück zum Zitat El-Miedany YM, Ashour S, Moustafa H, Ahmed I (2002) Altered levels of soluble adhesion molecules in patients with rheumatoid arthritis complicated by peripheral neuropathy. J Rheumatol 29:57–61 El-Miedany YM, Ashour S, Moustafa H, Ahmed I (2002) Altered levels of soluble adhesion molecules in patients with rheumatoid arthritis complicated by peripheral neuropathy. J Rheumatol 29:57–61
14.
Zurück zum Zitat Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324. doi:10.1002/art.1780310302 PubMedCrossRef Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324. doi:10.​1002/​art.​1780310302 PubMedCrossRef
15.
Zurück zum Zitat Cardiel MH, Abello-Banfi M, Ruiz-Mercado R, Alarcon-Segovia D (1993) How to measure health status in rheumatoid arthritis in non-English speaking patients: validation of a Spanish version of the Health Assessment Questionnaire Disability Index (Spanish HAQ-DI). Clin Exp Rheumatol 11:117–121PubMed Cardiel MH, Abello-Banfi M, Ruiz-Mercado R, Alarcon-Segovia D (1993) How to measure health status in rheumatoid arthritis in non-English speaking patients: validation of a Spanish version of the Health Assessment Questionnaire Disability Index (Spanish HAQ-DI). Clin Exp Rheumatol 11:117–121PubMed
16.
Zurück zum Zitat Maury CP, Liljeström M, Laiho K, Tiitinen S, Kaarela K, Hurme M (2003) Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis. Arthritis Rheum 48:3068–3076. doi:10.1002/art.11294 PubMedCrossRef Maury CP, Liljeström M, Laiho K, Tiitinen S, Kaarela K, Hurme M (2003) Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis. Arthritis Rheum 48:3068–3076. doi:10.​1002/​art.​11294 PubMedCrossRef
17.
Zurück zum Zitat Kuuliala A, Eberhardt K, Takala A, Kautiainen H, Repo H, Leirisalo-Repo M (2002) Circulating soluble E-selectin in early rheumatoid arthritis: a prospective five-year study. Ann Rheum Dis 61:242–246. doi:10.1136/ard.61.3.242 PubMedCrossRef Kuuliala A, Eberhardt K, Takala A, Kautiainen H, Repo H, Leirisalo-Repo M (2002) Circulating soluble E-selectin in early rheumatoid arthritis: a prospective five-year study. Ann Rheum Dis 61:242–246. doi:10.​1136/​ard.​61.​3.​242 PubMedCrossRef
20.
Zurück zum Zitat Vallien G, Langley R, Jennings S, Specian R, Granger DN (2000) Expression of endothelial cell adhesion molecules in neovascularized tissue. Microcirculation 7:249–258. doi:10.1080/713773980 PubMedCrossRef Vallien G, Langley R, Jennings S, Specian R, Granger DN (2000) Expression of endothelial cell adhesion molecules in neovascularized tissue. Microcirculation 7:249–258. doi:10.​1080/​713773980 PubMedCrossRef
21.
Zurück zum Zitat Dessein PH, Joffe BI, Singh S (2005) Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther 7:634–643. doi:10.1186/ar1717 CrossRef Dessein PH, Joffe BI, Singh S (2005) Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther 7:634–643. doi:10.​1186/​ar1717 CrossRef
22.
Metadaten
Titel
Circulating E-selectin and tumor necrosis factor-α in extraarticular involvement and joint disease activity in rheumatoid arthritis
verfasst von
Esther G. Corona-Sanchez
Laura Gonzalez-Lopez
Jose F. Muñoz-Valle
Monica Vazquez-Del Mercado
Maria A. Lopez-Olivo
Erika A. Aguilar-Chavez
Mario Salazar-Paramo
Carlos Loaiza-Cardenas
Edith Oregon-Romero
Rosa E. Navarro-Hernandez
Jorge I. Gamez-Nava
Publikationsdatum
01.01.2009
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 3/2009
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0688-3

Weitere Artikel der Ausgabe 3/2009

Rheumatology International 3/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.